MindMed to Participate in June Conferences
2024年5月28日 - 8:00PM
ビジネスワイヤ(英語)
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or
“MindMed”), a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders, announced
today that members of the Company’s management team will
participate in the following conferences:
- BIO International Convention 2024
- Panel Name: Challenging Biotech’s One-Track Mind When it Comes
to Neuropsychiatric Drug Innovation
- Date and Time: Tuesday, June 4, 2024 at 4:15 pm PDT
- Location: San Diego, CA
- Jefferies 2024 Global Healthcare Conference
- Format: 1x1 investor meetings only
- Dates: June 5-6, 2024
- Location: New York, NY
About MindMed
MindMed is a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders. Our
mission is to be the global leader in the development and delivery
of treatments that unlock new opportunities to improve patient
outcomes. We are developing a pipeline of innovative product
candidates, with and without acute perceptual effects, targeting
neurotransmitter pathways that play key roles in brain health
disorders. MindMed trades on NASDAQ under the symbol MNMD.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240528659571/en/
For Media: media@mindmed.co For Investors:
ir@mindmed.co
Mind Medicine MindMed (NASDAQ:MNMD)
過去 株価チャート
から 5 2024 まで 6 2024
Mind Medicine MindMed (NASDAQ:MNMD)
過去 株価チャート
から 6 2023 まで 6 2024